Case Study on Drug-Related Adverse Effects of Hepatitis C Therapy

Basit Öğe Kaydı
dc.contributor.authorBaşaranoğlu, Metin
dc.contributor.authorÇelebi, Selman
dc.contributor.authorKaraaslan, Hayri
dc.contributor.authorDemir, Ali
dc.date.accessioned2020-03-26T17:03:09Z
dc.date.available2020-03-26T17:03:09Z
dc.date.issued2006
dc.departmentSelçuk Üniversitesien_US
dc.description.abstractThe case of a 46-year-old woman with chronic hepatitis C who was prescribed subcutaneous pegylated interferon once a week and oral ribavirin once a day is presented. Within 24 h after the first injection to her left arm, the patient developed pruritus and erythematous papules at the injection site and painful papules on her hands. After immediate administration of antihistamines, the pruritus and papules remitted. One wk later, after injection in the right arm, skin lesions and pruritus were seen. After the third injection to the abdomen, the patient developed a rash, and after the fourth and fifth injections to other areas of the abdomen, injection-site papules were seen. The patient had no skin reactions for the next 12 mo, with the exception of injection-site papules. Hepatitis C virus RNA was negative after 12 mo of treatment. Clearly, patience is important during hepatitis C therapy in order to avoid unnecessary examinations and to promote successful outcomes.en_US
dc.identifier.citationBaşaranoğlu, M., Çelebi, S., Karaaslan, H., Demir, A., (2006). Case Study on Drug-Related Adverse Effects of Hepatitis C Therapy. Advances in Therapy, 23(5), 769-771. Doi: 10.1007/BF02850316
dc.identifier.doi10.1007/BF02850316en_US
dc.identifier.endpage771en_US
dc.identifier.issn0741-238Xen_US
dc.identifier.issue5en_US
dc.identifier.pmid17142211en_US
dc.identifier.scopusqualityQ1en_US
dc.identifier.startpage769en_US
dc.identifier.urihttps://dx.doi.org/10.1007/BF02850316
dc.identifier.urihttps://hdl.handle.net/20.500.12395/20369
dc.identifier.volume23en_US
dc.identifier.wosWOS:000242883400012en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.institutionauthorBaşaranoğlu, Metin
dc.institutionauthorÇelebi, Selman
dc.institutionauthorKaraaslan, Hayri
dc.institutionauthorDemir, Ali
dc.language.isoenen_US
dc.publisherHealth Communications Incen_US
dc.relation.ispartofAdvances in Therapyen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.selcuk20240510_oaigen_US
dc.subjecthepatitis C therapyen_US
dc.subjectpegylated interferonen_US
dc.subjectribavirinen_US
dc.subjectskin rashen_US
dc.titleCase Study on Drug-Related Adverse Effects of Hepatitis C Therapyen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
20369.pdf
Boyut:
171.61 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
İç Hastalıkları/Makale Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu